Stephen Oesterle

Non Executive / Other Non-Executive
  • Director Verified:
  • No
Login/ Register  to follow report
Linkedn: https://www.linkedin.com/in/stephen-oesterle/Visit Page
Company:

About

Stephen N. Oesterle, M.D. has served as a director of Baxter since February 2017.

Oesterle is a consultant, advising private equity and operating companies in the healthcare industry. From 2002 to 2015, he was a member of the Executive Committee of Medtronic plc (Medtronic), serving as Senior Vice President of Medicine and Technology. Previously, he served as an Associate Professor of Medicine and Director of Invasive Cardiology Services at each of Massachusetts General Hospital (1998 to 2002), Stanford University Medical Center (1992 to 1998) and Georgetown University Medical Center (1991 to 1992). Oesterle currently serves as director of Paragon 28, Peijia Medical, and Sigilon Therapeutics, Inc. He previously served as a director of Monte Archimedes Acquisition Corp. from October 2020 to October 2021, prior to its merger with Roivant, REVA Medical, Inc. from February 2018 to May 2019 and of HeartWare International, Inc. (HeartWare) from January 2016 to November 2016, prior to Medtronic’s acquisition of HeartWare.

 

Personal Details

Title: Dr
Surname: Oesterle
M/F: Male
Nationality: American
Country of Birth: United States of America
Language: English
Qualification: Doctor of Medicine MD, Bachelor of ARTS IN Chemistry
Industry:

 

Qualifications & Experience

 

Industry Experience +5yrs:
Industry Qualification +5yrs?:
Finance experience +5yrs?:
Finance Qualification +5yrs:
Legal experience +5yrs?:
Delinquent director?:
Other Experiences?:
Collapsed company director?:

 

Other directorships (state)

(only entities turnover at least $5m p/a)

 

Working history

Name

Vice President

Medtronic
Appointed Date: 01/01/2002
Date Resigned: 01/01/2015
Industry: Healthcare

View Company

 

Committee/s

CompanyCommitteeRoleAppointment DateResignation Date
Baxter InternationalNominations & GovernanceChairperson01/02/2017
Baxter InternationalSupervisory BoardChairperson01/02/2017
Baxter InternationalBoardChairperson01/02/2017
Baxter InternationalRisk & ComplianceChairperson01/02/2017
Baxter InternationalTechnologyChairperson01/02/2017

 

Independence Questions

Any family members working for the company?:
Are you doing business with the company?:
Do you hold shares in the company for more than 0.10%? (directly or by representation):
Is your Director annual fee more than 5% of your total income from all sources?:
Are you more than 10 years as a director?:
Are you an executive chairperson?:
InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.
Download PDF